Chang Jason J, Dowlati Ehsan, Felbaum Daniel R, Mai Jeffrey C
MedStar Washington Hospital Center, Department of Critical Care Medicine, Washington, DC, USA.
Turk Neurosurg. 2022;32(6):1038-1042. doi: 10.5137/1019-5149.JTN.38377-22.3.
Patients with aneurysmal subarachnoid hemorrhage (SAH) continue to have poor functional outcome due to the occurrence of delayed cerebral ischemia (DCI). Although vasospasm represents the primary therapeutic target for mitigating DCI, DCI occurs through multifocal etiologies that involve impaired cerebral autoregulation. Worse pressure reactivity index (PRx) values, which consists of a moving correlation coefficient between intracranial pressures and mean arterial pressures, have been shown to be associated with DCI in non-randomized clinical trials. Here, we discuss two patients that presented with high-grade SAH and comatose exams. Patient one was a 34-year-old male diagnosed with SAH from a ruptured right middle cerebral artery aneurysm. He had intact PRx values (Mean: -0.07 during hospital days 9-19), while having severe, refractory vasospasm. At the conclusion of his hospitalization, he was functionally independent, had negligible DCI, and was successfully discharged home. Patient two was a 78-year-old female diagnosed with SAH from a ruptured anterior communicating artery aneurysm. She had an improving PRx ranging from -0.1 to 0.1 early in her hospitalization. However, upon developing severe vasospasm, her PRx increased to 0.6 (overall PRx from hospital days 4-16 was 0.3), and she suffered from extensive DCI in bilateral middle cerebral and anterior cerebral artery distributions that ultimately resulted in malignant cerebral edema and brain death. In conclusion, cerebral autoregulation as measured by PRx may represent a viable target for neuroprognostication by evaluating DCI risk in patients with SAH who develop severe or refractory vasospasm. Further studies evaluating the role of cerebral autoregulation, PRx, and its pathophysiological role in DCI are warranted.
由于迟发性脑缺血(DCI)的发生,动脉瘤性蛛网膜下腔出血(SAH)患者的功能预后仍然很差。尽管血管痉挛是减轻DCI的主要治疗靶点,但DCI是由多因素病因引起的,包括脑自动调节功能受损。压力反应性指数(PRx)值由颅内压与平均动脉压之间的移动相关系数组成,在非随机临床试验中,较差的PRx值已被证明与DCI相关。在此,我们讨论两名表现为高级别SAH且昏迷检查的患者。患者一是一名34岁男性,因右侧大脑中动脉动脉瘤破裂被诊断为SAH。他的PRx值正常(住院第9 - 19天平均值为 - 0.07),但患有严重的难治性血管痉挛。住院结束时,他功能独立,DCI可忽略不计,并成功出院回家。患者二是一名78岁女性,因前交通动脉动脉瘤破裂被诊断为SAH。住院早期她的PRx从 - 0.1改善到0.1。然而,在出现严重血管痉挛后,她的PRx增加到0.6(住院第4 - 16天的总体PRx为0.3),并且在双侧大脑中动脉和大脑前动脉分布区域发生了广泛的DCI,最终导致恶性脑水肿和脑死亡。总之,通过PRx测量的脑自动调节功能可能是评估发生严重或难治性血管痉挛的SAH患者DCI风险的神经预后可行指标。有必要进一步研究评估脑自动调节功能、PRx及其在DCI中的病理生理作用。